Limited time75% off all plans
Get the app

Fractionation in Radiotherapy

Fractionation in Radiotherapy

Fractionation in Radiotherapy

On this page

Fractionation Fundamentals - Dose Delivery Dance

  • Definition: Dividing total radiotherapy dose into multiple smaller, daily fractions over weeks.
  • Aim: Enhance therapeutic ratio: maximize tumor damage, minimize normal tissue injury.
  • The 4 R's of Radiobiology:
    • Repair: Normal tissues repair sublethal damage (SLD) more efficiently.
    • Reoxygenation: Hypoxic tumor regions gain O₂, ↑ radiosensitivity.
    • Redistribution: Cells enter radiosensitive cell cycle phases (G2/M).
    • Repopulation: Normal cells regenerate; tumor cells too if overall treatment time is protracted.
  • Standard: 1.8-2 Gy/fraction, daily, 5x/week.

⭐ Fractionation primarily exploits differential repair in normal tissues and reoxygenation in tumors, improving therapeutic outcomes.

The 5 R's of Radiobiology - Cell Survival Saga

The biological basis for fractionation's success. 📌 Key principles:

  • Repair: Normal tissues repair Sublethal Damage (SLD) more efficiently than tumors between fractions. Allows normal tissue sparing.
  • Repopulation: Surviving normal and tumor cells divide between fractions. Can be detrimental if tumor repopulation is fast; prolonging treatment time can ↓ local control.
  • Reoxygenation: Hypoxic (radioresistant) tumor core cells gain oxygen access as outer cells die, becoming more radiosensitive.
  • Redistribution (Reassortment): Surviving cells progress through the cell cycle. Fractionation catches more cells in sensitive phases (G2/M).
  • Radiosensitivity: Intrinsic differences in radiation sensitivity among cells and tumor types. Fractionation exploits these differences.

⭐ Reoxygenation is critical: hypoxic cells can be 2-3 times more radioresistant than normoxic cells. Fractionation helps overcome this tumor radioresistance mechanism.

Scheduling Strategies - Time-Dose Tactics

Fractionation exploits differences in repair capacity (one of the 5 R's) between tumor and normal tissues. Based on Linear-Quadratic (LQ) model: $E = n(\alpha d + \beta d^2)$. Biologically Effective Dose (BED) = $D(1 + d/(\alpha/\beta))$ helps compare schedules.

  • α/β ratio: Tumors ≈ 10 Gy (early effects); Late-responding tissues ≈ 3 Gy.
ScheduleDose/Fx (Gy)Fx/DayOverall TimeTotal DoseRationale/Impact
Conventional (CF)1.8-2.016-7 wksStandardStandard; Balanced efficacy & toxicity.
Hyperfractionation (HF)1.1-1.2 (↓)2-3Similar↓ Late toxicity (spares low α/β tissues); ≥6h interval.
Accelerated (AF)Standard/↓≥1↓ (<6 wks)Similar/↓↓ Repopulation in fast tumors; ↑ Acute toxicity.
Hypofractionation (HypoF)>2.5 (↑)1Low α/β tumors (e.g., prostate); Palliative; ↑ Late effects risk.
CHART1.5312 days54 GyContinuous (no weekend break); ↓ Repopulation; ↑ Acute mucosal tox.

LQ Model & BED - Radiobiologic Math

  • Linear-Quadratic (LQ) Model: Predicts cell kill from radiation.
    • Total biological effect: $E = n(\alpha d + \beta d^2)$.
      • $n$: number of fractions, $d$: dose/fraction.
    • $\alpha$ component: irreparable DNA damage (linear cell kill).
    • $\beta$ component: repairable/misrepaired DNA damage (quadratic cell kill).
    • $\alpha/\beta$ ratio: Measures fractionation sensitivity.
      • Tumors & acute effects: ~10 Gy (less sensitive to changes in $d$).
      • Late effects: ~3 Gy (more sensitive to changes in $d$; sparing with lower $d$).
  • Biologically Effective Dose (BED): Total biological impact of a radiotherapy schedule.
    • Formula: $BED = D(1 + d/(\alpha/\beta))$.
      • $D$: total physical dose ($nd$).
    • Allows isoeffective dose calculations for different fractionation regimens.

    ⭐ For late-responding tissues (low $\alpha/\beta$), BED increases significantly with larger fraction sizes ($d$), potentially increasing late toxicity. LQ Model Cell Survival Curve with Alpha/Beta Ratios

High‑Yield Points - ⚡ Biggest Takeaways

  • Fractionation improves therapeutic ratio by exploiting the 4 R's: Repair, Repopulation, Reoxygenation, Redistribution.
  • BED compares schedules using total dose, dose/fraction, and α/β ratio.
  • Late-responding tissues have low α/β ratios (e.g., ~3 Gy), spared by smaller fractions.
  • Tumors & early-responding tissues usually have high α/β ratios (e.g., ~10 Gy).
  • Hyperfractionation (smaller dose/fraction) aims to ↓ late toxicity.
  • Hypofractionation (larger dose/fraction) for palliative care or specific tumors_._

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE